DOVMYA Trademark

Trademark Overview

On Wednesday, September 12, 2018, a trademark application was filed for DOVMYA with the United States Patent and Trademark Office. The USPTO has given the DOVMYA trademark a serial number of 88114380. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 24, 2021. This trademark is owned by Mylan Pharmaceuticals, Inc.. The DOVMYA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diabetes
dovmya

General Information

Serial Number88114380
Word MarkDOVMYA
Filing DateWednesday, September 12, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 24, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 26, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diabetes
Translation of Words in MarkThe wording "DOVMYA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 20, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMylan Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26505
Party NameMylan Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26505

Trademark Events

Event DateEvent Description
Monday, May 24, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 24, 2021ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 22, 2020EXTENSION 3 GRANTED
Thursday, October 22, 2020EXTENSION 3 FILED
Thursday, October 22, 2020TEAS EXTENSION RECEIVED
Wednesday, April 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 20, 2020EXTENSION 2 GRANTED
Monday, April 20, 2020EXTENSION 2 FILED
Monday, April 20, 2020TEAS EXTENSION RECEIVED
Tuesday, October 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 18, 2019EXTENSION 1 GRANTED
Friday, October 18, 2019EXTENSION 1 FILED
Friday, October 18, 2019TEAS EXTENSION RECEIVED
Tuesday, April 23, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 26, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 16, 2019ASSIGNED TO LIE
Saturday, December 22, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 12, 2018EXAMINER'S AMENDMENT ENTERED
Wednesday, December 12, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, December 12, 2018EXAMINERS AMENDMENT E-MAILED
Wednesday, December 12, 2018EXAMINERS AMENDMENT -WRITTEN
Friday, December 7, 2018ASSIGNED TO EXAMINER
Thursday, September 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, September 15, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

dovmya diabetes treatment preparations pharmaceutical